Study title: The presence of alpha thalassemia trait blunts the response of hydroxycarbamide in patients with Sickle Cell Disease2008
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: HYDROXYUREA | |||||
ATC code: | |||||
Document link: 18764867.pdf | |||||
Document date: 2014-01-13 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Review Article | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |